Download Phox2b and Midkine/Alk signaling in the control of sympathetic

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Epigenetics of human development wikipedia , lookup

Frameshift mutation wikipedia , lookup

Wnt signaling pathway wikipedia , lookup

Gene expression profiling wikipedia , lookup

RNA-Seq wikipedia , lookup

Site-specific recombinase technology wikipedia , lookup

Gene expression programming wikipedia , lookup

Epistasis wikipedia , lookup

Mutation wikipedia , lookup

Oncogenomics wikipedia , lookup

Epigenetics of depression wikipedia , lookup

Polycomb Group Proteins and Cancer wikipedia , lookup

Point mutation wikipedia , lookup

Nutriepigenomics wikipedia , lookup

Epigenetics of neurodegenerative diseases wikipedia , lookup

Secreted frizzled-related protein 1 wikipedia , lookup

Mir-92 microRNA precursor family wikipedia , lookup

NEDD9 wikipedia , lookup

Transcript
PHOX2B AND MIDKINE/ALK SIGNALING IN THE CONTROL OF SYMPATHETIC NEURON
PROLIFERATION AND NEUROBLASTOMA PREDISPOSITION
Tobias Reiff1, Leslie Huber1, Konstantina Tsarovina1, Afsaneh Majdazari1, Marco Kramer1, Mirko
Schmidt1, Isabel del Pino1, Olivier Delattre2, Isabelle Janoueix-Lerosey2, and Hermann Rohrer1,#
1
Research Group Developmental Neurobiology; Max Planck Institute for Brain Research,
Deutschordenstr. 46, 60528, Frankfurt/M, Germany
2
Unité Inserm U830, Centre de Recherche Institut Curie, 26, rue d'Ulm, 75248 Paris Cedex 05,
France
#
presenting author
Neuroblastoma (NB) is the most common extracranial solid tumor in childhood and arises from cells
of the developing sympathoadrenal lineage. Mutations in PHOX2B and ALK genes have been
observed in familial and sporadic forms of NB and represent the first defined genetic predisposition
for neuroblastoma. We have addressed the mechanisms that may underlie this predisposition using a
developmental biology approach, comparing the function of wild-type (wt) and mutant (mut)
proteins, ectopically expressed in proliferating, embryonic sympathetic neurons. Phox2bwt displays a
strong antiproliferative effect, which is lost in all Phox2bmut NB variants analyzed. In contrast,
Phox2bmut elicits an increase in sympathetic neuron proliferation, both in vitro and in vivo. The
elevated proliferation is blocked by knockdown of the transcription factor Hand2 and the
antiproliferative Phox2b effects are rescued by Hand2 overexpression, implying Hand2 in Phox2bmediated proliferation control.
Forced expression of wild-type ALK and NB-related constitutively-active ALK mutants in cultures of
proliferating embryonic sympathetic neurons results in a strong proliferation increase whereas Alk
knockdown and pharmacological inhibition of Alk activity decrease proliferation. Alk activation
upregulates NMyc and trkB and maintains Alk expression by an autoregulatory mechanism involving
Hand2. The Alk-ligand Midkine (Mk) is expressed in immature sympathetic neurons and in vivo
inhibition of Alk signaling by virus-mediated shRNA knockdown of Alk and Mk leads to strongly
reduced sympathetic neuron proliferation. Taken together, these results demonstrate that the
extent and timing of sympathetic neurogenesis is controlled by Mk/Alk signaling. NB predisposition
by activating ALK mutations may thus be explained by aberrations of normal neurogenesis, i.e.
elevated and sustained Alk signaling and increased NMyc expression.
Mutations in ALK and PHOX2B seem to share a common predisposition mechanism, i.e. increased
and/or prolonged proliferation during sympathetic neurogenesis. The effects are linked by Hand2,
which is involved in the proliferation control exerted by both Phox2b and Mk/Alk signaling. The
selective expression of Hand2 and Alk in the sympathoadrenal lineage provides an explanation for
the restriction of NB to this part of the autonomic nervous system.